KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Gross Profit (2016 - 2025)

Historic Gross Profit for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $6.5 billion.

  • Amgen's Gross Profit rose 2468.71% to $6.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $23.8 billion, marking a year-over-year increase of 2094.94%. This contributed to the annual value of $20.6 billion for FY2024, which is 418.97% up from last year.
  • Latest data reveals that Amgen reported Gross Profit of $6.5 billion as of Q3 2025, which was up 2468.71% from $6.2 billion recorded in Q2 2025.
  • In the past 5 years, Amgen's Gross Profit registered a high of $6.5 billion during Q3 2025, and its lowest value of $4.2 billion during Q1 2024.
  • Its 5-year average for Gross Profit is $5.1 billion, with a median of $5.1 billion in 2021.
  • As far as peak fluctuations go, Amgen's Gross Profit crashed by 624.33% in 2023, and later soared by 2468.71% in 2025.
  • Amgen's Gross Profit (Quarter) stood at $5.1 billion in 2021, then fell by 0.7% to $5.1 billion in 2022, then fell by 0.16% to $5.1 billion in 2023, then increased by 17.51% to $6.0 billion in 2024, then increased by 8.39% to $6.5 billion in 2025.
  • Its Gross Profit was $6.5 billion in Q3 2025, compared to $6.2 billion in Q2 2025 and $5.2 billion in Q1 2025.